Used primarily as a key intermediate in the synthesis of antimalarial drugs, particularly in the development of quinoline-based pharmaceuticals. Its structure supports the creation of compounds that inhibit hemozoin formation in Plasmodium species, thereby disrupting the parasite's ability to detoxify heme during red blood cell infection. Also explored for potential antiviral and anticancer applications due to its ability to intercalate into nucleic acids and interfere with cellular replication processes. Employed in research settings to design novel bioactive molecules with improved pharmacokinetic and resistance profiles.